Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.
Pharma major Novartis falls nearly 10%, heading for worst day on record after three drug trial setbacks
Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.
About the Author
Previous Post
Next Post
Leave a Reply
Latest News
Stay Connected
Categories
Business Health India Politics Science Sports Technology Uncategorized World
Tags
About the Author
AF themes
Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.
Search the Archives
Access over the years of investigative journalism and breaking reports
You May Have Missed
